Skip to content
Search

Latest Stories

DH issues supply disruption alert for estradot 75 micrograms patches

The Department of Health and Social Care (DH) has issued a supply alert for Estradot 75 microgram patches following a significant supply disruption.

The Serious Supply Protocol is currently scheduled to end on June 4.


Effective from today (April 29), SSP012 provides that for every Estradot 75 microgram patch originally prescribed, either one Evorel 75 microgram patch or one Estraderm MX 75 microgram patch must be supplied.

Product details

For prescriptions (NHS or private) requesting:Supply permitted under SSP012:
Estradot® 75 microgram patchesEvorel® 75 microgram patches

OR

Estraderm MX® 75 microgram patches

“Contractors will receive an email to their shared NHSmail account informing them of this SSP and pharmacy teams are advised to read the documentation for SSP012 in full and to implement the protocol with immediate effect,” the Pharmaseutical Services Negotiating Committee (PSNC) said in an update to community pharmacists.

Guidelines for community pharmacists

  • ensure that patients considered unsuitable for inclusion are promptly referred to their prescriber for further advice
  • the supervising pharmacist should ensure that the patient’s prescriber is notified when supplying a patient in accordance with this SSP
  • the supervising pharmacist should explain to patients who are supplied in accordance with this SSP on monitoring and managing potential side effects, such as:
    • Vaginal ‘breakthrough bleeding’;
    • Irritation caused by wearing a different patch to one they are used to;
    • Patches coming off or not adhering properly.
  • patients who experience persistent side effects from alternative patches supplied in accordance with this SSP should be referred back to their prescriber promptly

Reimbursement

The community pharmacy contractors will be reimbursed the Drug Tariff Part VIIIA reimbursement price for Evorel 75 microgram patches or Estraderm MX 75 microgram patches. The reimbursement price will account for VAT payment. Supply in accordance with the SSP will result in the following fees being paid to the contractor:
  • One Single Activity fee (currently £1.27)
  • One SSP fee (£5.35)

More For You

Antibiotic prescribing for sore throats in England's pharmacies is twice as high as in Wales

Antibiotic supply rate was 72.7% under England’s Acute Sore Throat Pharmacy First compared to just 29.9% under Wales’ Sore Throat Test and Treat (STTT) scheme in six months.

Getty Images

Sore throat treatment: England pharmacies twice as likely to prescribe antibiotics as Welsh counterparts

A new study has highlighted significant differences in antibiotic use for sore throat treatment between pharmacies in England and Wales, suggesting that incorporating throat swabs to confirm bacterial infections could help reduce “unnecessary antibiotic supply.”

The study, published in the Journal of Antimicrobial Chemotherapy and first reported by The Independent, found that pharmacies in England were twice as likely to prescribe antibiotics for sore throats compared to those in Wales.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
NPA and IPA urge NHS England to release pharmacy economic analysis immediately

Pharmacy bodies call for transparency on the funding gap amid ongoing contract negotiations.

Getty Images

Pharmacy bodies demand immediate release of economic analysis

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) have jointly written to NHS England, demanding the immediate release of the independent economic analysis of pharmacy finances commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

Keep ReadingShow less
Discrimination: Asian and Black patients report lack of trust in primary care providers

Ethnic minority groups had worse experiences in their communication with their GP practice and felt taken less seriously

Getty Images

Survey reveals alarming rates of ethnic discrimination in NHS primary care

A recent survey by the NHS Race and Health Observatory has highlighted a worrying lack of trust in NHS primary care services among Black, Asian, and ethnic minority patients, who reported experiencing “racial or ethnic discrimination.”

Out of 2,680 survey respondents, only 55% reported trusting primary care providers to meet their health needs most or all of the time

Keep ReadingShow less